Morocco · Delayed Price · Currency is MAD Theseus Pharmaceuticals Statistics
Total Valuation
CBSE:BCI has a market cap or net worth of MAD 8.16 billion.
| Market Cap | 8.16B |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Wednesday, August 27, 2025.
| Earnings Date | Aug 27, 2025 |
| Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
CBSE:BCI has 13.28 million shares outstanding. The number of shares has increased by 2.55% in one year.
| Current Share Class | 13.28M |
| Shares Outstanding | 13.28M |
| Shares Change (YoY) | +2.55% |
| Shares Change (QoQ) | -0.91% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.01% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 24.97 and the forward PE ratio is 18.57.
| PE Ratio | 24.97 |
| Forward PE | 18.57 |
| PS Ratio | 2.73 |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 4.44%.
| Return on Equity (ROE) | 4.44% |
| Return on Assets (ROA) | 0.43% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 1.14M |
| Profits Per Employee | 127,158 |
| Employee Count | 2,621 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CBSE:BCI has paid 393.59 million in taxes.
| Income Tax | 393.59M |
| Effective Tax Rate | 54.53% |
Stock Price Statistics
The stock price has decreased by -2.41% in the last 52 weeks. The beta is -0.05, so CBSE:BCI's price volatility has been lower than the market average.
| Beta (5Y) | -0.05 |
| 52-Week Price Change | -2.41% |
| 50-Day Moving Average | 581.81 |
| 200-Day Moving Average | 594.37 |
| Relative Strength Index (RSI) | 60.83 |
| Average Volume (20 Days) | 12,668 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CBSE:BCI had revenue of MAD 2.99 billion and earned 333.28 million in profits. Earnings per share was 24.63.
| Revenue | 2.99B |
| Gross Profit | 2.99B |
| Operating Income | 728.01M |
| Pretax Income | 721.78M |
| Net Income | 333.28M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 24.63 |
Balance Sheet
The company has 3.52 billion in cash and 16.36 billion in debt, giving a net cash position of -12.84 billion or -966.98 per share.
| Cash & Cash Equivalents | 3.52B |
| Total Debt | 16.36B |
| Net Cash | -12.84B |
| Net Cash Per Share | -966.98 |
| Equity (Book Value) | 7.46B |
| Book Value Per Share | 559.83 |
| Working Capital | -49.47B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 24.36% |
| Pretax Margin | 24.15% |
| Profit Margin | 11.15% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 18.00, which amounts to a dividend yield of 2.93%.
| Dividend Per Share | 18.00 |
| Dividend Yield | 2.93% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.55% |
| Shareholder Yield | 0.38% |
| Earnings Yield | 4.08% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 6, 2006. It was a forward split with a ratio of 1.20482.
| Last Split Date | Jun 6, 2006 |
| Split Type | Forward |
| Split Ratio | 1.20482 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |